# Pemetrexed in Patients With Soft Tissue Sarcoma

> **NCT00427466** · PHASE2 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 54 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT00427466
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2009-02-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00427466

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00427466, "Pemetrexed in Patients With Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00427466. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*